UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization

Molecular carcinogenesis, 2019-07, Vol.58 (7), p.1118-1133

2019

Volltextzugriff (PDF)

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response

Frontiers in physiology, 2022-11, Vol.13

2022

Volltextzugriff (PDF)

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

Frontiers in immunology, 2024-02, Vol.15, p.1332939-1332939

2024

Volltextzugriff (PDF)

Expanding anti-CD38 immunotherapy for lymphoid malignancies

Journal of experimental & clinical cancer research, 2022-06, Vol.41 (1), p.1-210, Article 210

2022

Volltextzugriff (PDF)

AI-powered discovery of a novel p53-Y220C reactivator

Frontiers in oncology, 2023-08, Vol.13, p.1229696-1229696

2023

Volltextzugriff (PDF)

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice

Genes & diseases, 2024-07, Vol.11 (4), p.100994-100994, Article 100994

2024

Volltextzugriff (PDF)

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant

Journal of hematology and oncology, 2024-06, Vol.17 (1), p.45-23, Article 45

2024

Volltextzugriff (PDF)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5515

2021

Volltextzugriff (PDF)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

iScience, 2023-07, Vol.26 (7), p.107120-107120, Article 107120

2023

Volltextzugriff (PDF)

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis

Molecules (Basel, Switzerland), 2021-10, Vol.26 (20), p.6215

2021

Volltextzugriff (PDF)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

iScience, 2023-03, Vol.26 (3), p.106143-106143, Article 106143

2023

Volltextzugriff (PDF)

DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma

npj vaccines, 2024-10, Vol.9 (1), p.180-14, Article 180

2024

Volltextzugriff (PDF)

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma

npj vaccines, 2023-08, Vol.8 (1), p.109-109, Article 109

2023

Volltextzugriff (PDF)

Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction

Biochimica et biophysica acta. Molecular basis of disease, 2018-04, Vol.1864 (4), p.1115-1128

2018

Volltextzugriff (PDF)

Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe−/− mice

Atherosclerosis, 2022-09, Vol.356, p.28-40

2022

Volltextzugriff (PDF)

DOT1L regulates MTDH‐mediated angiogenesis in triple‐negative breast cancer: intermediacy of NF‐κB‐HIF1α axis

The FEBS journal, 2023-01, Vol.290 (2), p.502-520

2023

Volltextzugriff (PDF)

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials

Cancer treatment reviews, 2022-09, Vol.109, p.102429-102429, Article 102429

2022

Volltextzugriff (PDF)

AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation

The FEBS journal, 2015-10, Vol.282 (20), p.3971-3985

2015

Volltextzugriff (PDF)

AMPK inhibits MTDH expression via GSK3[beta] and SIRT1 activation: potential role in triple negative breast cancer cell proliferation

The FEBS journal, 2015-10, Vol.282 (20), p.3971

2015

Volltextzugriff (PDF)

A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis

Oncogene, 2020-03, Vol.39 (10), p.2088-2102

2020

Volltextzugriff (PDF)

A novel metadherin[DELTA]7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFA¸B-SIRT3 axis

Oncogene, 2020-03, Vol.39 (10), p.2088

2020

Volltextzugriff (PDF)

A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent

Chemical communications (Cambridge, England), 2021-11, Vol.57 (92), p.12329-12332

2021

Volltextzugriff (PDF)

sp3‐Rich Glycyrrhetinic Acid Analogues Using Late‐Stage Functionalization as Potential Breast Tumor Regressing Agents

ChemMedChem, 2020-10, Vol.15 (19), p.1826-1833

2020

Volltextzugriff (PDF)

sp 3 -Rich Glycyrrhetinic Acid Analogues Using Late-Stage Functionalization as Potential Breast Tumor Regressing Agents

ChemMedChem, 2020-10, Vol.15 (19), p.1826-1833

2020

Volltextzugriff (PDF)

AMPK inhibits MTDH expression via GSK 3β and SIRT 1 activation: potential role in triple negative breast cancer cell proliferation

The FEBS journal, 2015-10, Vol.282 (20), p.3971-3985

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

Expanding anti-CD38 immunotherapy for lymphoid malignancies

AI-powered discovery of a novel p53-Y220C reactivator

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma

Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction

Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe−/− mice

DOT1L regulates MTDH‐mediated angiogenesis in triple‐negative breast cancer: intermediacy of NF‐κB‐HIF1α axis

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials

AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation

AMPK inhibits MTDH expression via GSK3[beta] and SIRT1 activation: potential role in triple negative breast cancer cell proliferation

A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis

A novel metadherin[DELTA]7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFA¸B-SIRT3 axis

A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent

sp3‐Rich Glycyrrhetinic Acid Analogues Using Late‐Stage Functionalization as Potential Breast Tumor Regressing Agents

sp 3 -Rich Glycyrrhetinic Acid Analogues Using Late-Stage Functionalization as Potential Breast Tumor Regressing Agents

AMPK inhibits MTDH expression via GSK 3β and SIRT 1 activation: potential role in triple negative breast cancer cell proliferation

Suchergebnisse filtern